Medical Devices: Page 68
-
AdvaMed pushes Biden to use $52B chip program to support medtech supply chains
The group wants agencies to coordinate with the medtech industry to ensure investments are directed toward “technologies that power medical devices.”
By Nick Paul Taylor • Nov. 18, 2022 -
Philips’ ventilator woes grow as FDA issues alert over replacement foam
Replacement noise reduction material in Trilogy ventilators can block the air inlet and let trace amounts of particulate matter into the air pathway.
By Nick Paul Taylor • Nov. 18, 2022 -
Explore the Trendline➔
Sarah Silbiger via Getty ImagesTrendlineMedical device safety in spotlight after high profile recalls
From Philips’ massive recall of respiratory devices to ongoing health risks with breast implants, medical devices tied to patient harm have put a focus on product safety.
By MedTech Dive staff -
Medtronic’s renal denervation treatment ‘still a viable therapy’ despite study miss, doctors say
While the study missed its primary endpoint, the surgery likely will be an option for patients with drug-resistant hypertension.
By Elise Reuter • Nov. 17, 2022 -
Insulet warns Omnipod 5 insulin pump charge issue may cause fire
Rapid sales growth at the company has come amid safety problems involving some of its devices.
By Nick Paul Taylor • Nov. 17, 2022 -
Medtronic doubles wear time of insulin pump infusion sets
The company calculated users of its extended-wear system will change their devices 75 fewer times, resulting in annual savings of more than $1,000.
By Nick Paul Taylor • Nov. 16, 2022 -
Penumbra expands VR rehabilitation platform with lower body sensors
Adding lower body sensors will enable the company to target a wider range of health conditions.
By Nick Paul Taylor • Nov. 16, 2022 -
NFL expands program to use sensor-loaded mouthguards to gather head impact data
Data from the sensors could show what the human head experiences during an impact, improving efforts to reduce the incidence of concussions in football.
By Nick Paul Taylor • Nov. 15, 2022 -
Illumina cuts workforce by 5% amid supply chain woes, sales slowdown
The layoffs come as the firm wrestles with flat growth and a possible forced divestiture of its GRAIL cancer-detection unit.
By Nick Paul Taylor • Nov. 15, 2022 -
HHS cybersecurity center warns of new ransomware threat
Venus ransomware has attacked targets worldwide, including at least one U.S. health group, since it was first identified in mid-August.
By Susan Kelly • Nov. 14, 2022 -
Tandem pump, paired with Dexcom CGM, boosts blood glucose control in Type 2 diabetics
Patients with Type 2 diabetes spent 3.6 hours per day longer in the target blood glucose range after switching to Tandem’s system, a study found.
By Nick Paul Taylor • Nov. 14, 2022 -
Mayo Clinic creates product to test AI models for bias and inaccuracy
The proliferation of AI models has led to concerns about whether they work as intended.
By Nick Paul Taylor • Nov. 14, 2022 -
Green light shows promise in addressing oximetry racial bias: study
Researchers created a noninvasive device that performed comparably to Abbott’s invasive i-STAT in a small clinical trial.
By Nick Paul Taylor • Nov. 14, 2022 -
GE HealthCare prices offering of $8.25B in bonds as part of spinoff
The GE unit is stepping up its preparations to operate as an independent company.
By Nick Paul Taylor • Nov. 11, 2022 -
BD says inflationary pressures persist; COVID-19 test sales plunge
Revenue at the company’s medical segment grew in the fourth quarter, helped by the acquisition of pharmacy automation company Parata.
By Elise Reuter • Nov. 10, 2022 -
Medtech execs ‘rethink’ long-term strategies as care settings shift: Accenture report
The move from hospitals to ambulatory and at-home care is only just beginning, the survey found.
By Nick Paul Taylor • Nov. 10, 2022 -
J&J names Tezel global head of medtech R&D as Shen retires
The executive will take up the post as the company says it’s looking to innovation for future profits.
By Nick Paul Taylor • Nov. 10, 2022 -
Affordable alternative: Smartphone-based hearing test for infants targets developing countries
The off-the-shelf alternative has a material cost of $10, giving children in impoverished regions easier access to vital monitoring and diagnosis.
By Nick Paul Taylor • Nov. 9, 2022 -
Lilly’s new diabetes management platform to integrate Dexcom CGM
The launch comes seven years after the company began investing in device R&D to counter pricing pressures.
By Nick Paul Taylor • Nov. 9, 2022 -
Retrieved from Siemsens Website on July 01, 2022
Siemens Healthineers beats sales forecasts on imaging demand as diagnostic pressures prompt restructuring
Siemens Healthineers is revamping its diagnostics unit after concluding that “external headwinds [are] outweighing operational improvements.”
By Nick Paul Taylor • Nov. 9, 2022 -
Medtronic misses primary endpoint in renal denervation study
The device didn't outperform drug therapy when patients measured their blood pressure at home, though it's still expected to win FDA approval.
By Elise Reuter • Nov. 8, 2022 -
Verily’s Onduo cut blood sugar in retrospective study of Type 2 diabetics
Participants with high blood sugar at baseline benefited the most from Onduo, a study found.
By Nick Paul Taylor • Nov. 8, 2022 -
Power play: How harvesting energy from lungs may end need to replace batteries in brain stimulators
Researchers, aiming to prolong the life of powered devices that stimulate vital organs, are looking to bio-mechanics while also reducing the need for regular surgery to change batteries.
By Nick Paul Taylor • Nov. 8, 2022 -
Medtronic’s AFib ablation device beats antiarrhythmic drugs in 3-year study
Arctic Front cryoablation devices show promise as an early treatment for atrial fibrillation.
By Nick Paul Taylor • Nov. 8, 2022 -
iRhythm analysis shows savings from patients wearing Zio XT cardiac monitor patch
Scientists who performed the study say using the patch will save healthcare systems money by enabling early diagnosis.
By Peter Green • Nov. 7, 2022 -
5 takeaways from the FDA’s list of AI-enabled medical devices
As the number of devices increases, the agency is looking to adapt its regulatory framework to the new technology, including faster approval of algorithm updates.
By Elise Reuter • Nov. 7, 2022